160 related articles for article (PubMed ID: 2210020)
1. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes.
Robert JJ; Magre J; Reynet C; Darmaun D; Picard J; Capeau J
Diabete Metab; 1990; 16(3):240-7. PubMed ID: 2210020
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of insulin resistance in Turner syndrome.
Stoppoloni G; Prisco F; Alfano C; Iafusco D; Marrazzo G; Paolisso G
Diabete Metab; 1990; 16(4):267-71. PubMed ID: 1979950
[TBL] [Abstract][Full Text] [Related]
3. Metabolic studies in lipoatrophic diabetes: mechanism of hyperglycemia and evidence of resistance to insulin of lipid metabolism.
Beylot M; Sautot G; Laville M; Cohen R
Diabete Metab; 1988; 14(1):20-4. PubMed ID: 3292304
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
5. Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.
Boyd K; Boreham C; Andrews WJ; Hadden DR
Diabetes Res; 1991 Nov; 18(3):101-8. PubMed ID: 1841819
[TBL] [Abstract][Full Text] [Related]
6. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
[TBL] [Abstract][Full Text] [Related]
7. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
[TBL] [Abstract][Full Text] [Related]
8. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
Yki-Järvinen H; Koivisto VA
J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
[TBL] [Abstract][Full Text] [Related]
10. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and diabetes due to a genetic defect in insulin receptors.
Scarlett JA; Kolterman OG; Moore P; Saekow M; Insel J; Griffin J; Mako M; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1982 Jul; 55(1):123-31. PubMed ID: 7042734
[TBL] [Abstract][Full Text] [Related]
12. The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes.
Robert JJ; Rakotoambinina B; Cochet I; Foussier V; Magre J; Darmaun D; Chevenne D; Capeau J
Diabetologia; 1993 Dec; 36(12):1288-92. PubMed ID: 8307257
[TBL] [Abstract][Full Text] [Related]
13. Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure.
Schmitz O
Dan Med Bull; 1991 Feb; 38(1):36-52. PubMed ID: 2026051
[TBL] [Abstract][Full Text] [Related]
14. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
[TBL] [Abstract][Full Text] [Related]
15. Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs.
Gjessing PF; Fuskevåg OM; Hagve M; Revhaug A; Irtun Ø
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1305-12. PubMed ID: 20371732
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.
Haneda M; Polonsky KS; Bergenstal RM; Jaspan JB; Shoelson SE; Blix PM; Chan SJ; Kwok SC; Wishner WB; Zeidler A
N Engl J Med; 1984 May; 310(20):1288-94. PubMed ID: 6371526
[TBL] [Abstract][Full Text] [Related]
17. Mechanism and significance of insulin resistance in myotonic dystrophy.
Vialettes B; Pouget J; Viard R; Moulin JP; Serratrice G; Vague P
Horm Metab Res; 1986 Jun; 18(6):395-9. PubMed ID: 3525363
[TBL] [Abstract][Full Text] [Related]
18. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
19. [Hyperinsulinism syndromes caused by insulin resistance].
Robert JJ
Ann Pediatr (Paris); 1990 Mar; 37(3):143-9. PubMed ID: 2190520
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
Yki-Järvinen H; Koivisto VA
J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
